ReviewPharmaceuticals (Basel, Switzerland)2026

Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis.

Helal F Hetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.